ArticleAsian journal of andrology

PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: evidence from patients in Northwestern China.

Kai-Jie Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.